Posts tagged: Aurinia Pharmaceuticals

Betaville Intelligence

UNCOOKED ALERT: Aurinia Pharmaceuticals said to ... - Part 11

Thursday, 11 May 2023, 8:40 am

Another major shareholder in US-listed biopharmaceutical company Aurinia Pharmaceuticals has publicly come out against the board of the company.

Iljin, a longtime Korean investor in Aurinia with just over 6.1pc of the company, has written a letter to the board saying it does not intend to support the company's chairman, George Milne, along with several other board members, including Joseph Hagan...

Read more...

Betaville Intelligence

UNCOOKED ALERT: Aurinia Pharmaceuticals said to ... - Part 9

Thursday, 23 March 2023, 7:18 pm

One of Aurinia Pharmaceutical's largest shareholders has formally submitted an application for a seat on the board of the US-listed company and reiterated its request for the group to consider a formal sale of the business.

The MKT Tactical Fund, which owns 3.2pc of Aurinia Pharmaceuticals, submitted the request for the board seat this week to Aurinia's chief executive, Peter Greenleaf, and chairman, George Milne Junior...

Read more...

GlaxoSmithKline said to be eyeing £1 billion plus takeover bid for Theravance Biopharma, reports The Times

Friday, 11 February 2022, 8:21 am

Has GlaxoSmithKline truly given up its pursuit of Aurinia Pharmaceuticals, the US-listed drug developer?

Last year Betaville Intelligence reported that GSK was one of the pharmaceutical giants circling Aurinia but now The Times is reporting the FTSE 100-listed group is looking at a different takeover target...

Read more...

Betaville Intelligence

UNCOOKED ALERT: Aurinia Pharmaceuticals said to ... - Part 2

Friday, 22 October 2021, 9:51 pm

Rivals at Bloomberg appear at the moment to be super keen on following up little old Betaville's alerts.

Earlier this week the financial media behemoth followed Betaville's UNCOOKED Alert on Falck Renewables, the Italy-listed renewable energy group, and just now Bloomie followed up last week's UNCOOKED Alert on Aurinia Pharmaceuticals, the US-listed rare disease developer. Below is the link to a Seeking Alpha summary:..

Read more...